Evidence map›Paper›PMID 27454064›Full record

ArticleBiomaterials2016

In vivo biodistribution studies and ex vivo lymph node imaging using heavy metal-free quantum dots.

Elnaz Yaghini, Helen D Turner, Alix M Le Marois, Klaus Suhling, Imad Naasani, Alexander J MacRobert

Open access · hybridAbstract read
In one paragraph

Article in Biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Population pharmacokinetic modelling of indium-based quantum dot nanoparticles: preclinical in vivo studies.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2021
    Review
  6. Article
  7. Image-guided tumor surgery: The emerging role of nanotechnology.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Quantum dots in imaging, drug delivery and sensor applications.International journal of nanomedicine · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Elnaz YaghiniDivision of Surgery and Interventional Science and Institute of Healthcare Engineering, University College London, London, UK. Electronic address: elnaz.yaghini@ucl.ac.uk.
Helen D TurnerNanoco Technologies Ltd., 46 Grafton Street, Manchester, UK.
Alix M Le MaroisDepartment of Physics, King's College London, London, UK.
Klaus SuhlingDepartment of Physics, King's College London, London, UK.
Imad NaasaniNanoco Technologies Ltd., 46 Grafton Street, Manchester, UK.
Alexander J MacRobertDivision of Surgery and Interventional Science and Institute of Healthcare Engineering, University College London, London, UK.
King's College London · GBNanoco Technologies (United Kingdom) · GBUniversity College Hospital · GBUniversity College London · GB

Funding

Medical Research Council MC_PC_14093
6 · The paper itself

Abstract

Quantum dots (QDs) are attractive photoluminescence probes for biomedical imaging due to their unique photophysical properties. However, the potential toxicity of QDs has remained a major obstacle to their clinical use because they commonly incorporate the toxic heavy metal cadmium within the core of the QDs. In this work, we have evaluated a novel type of heavy metal-free/cadmium-free and biocompatible QD nanoparticles (bio CFQD(®) nanoparticles) with a good photoluminescence quantum yield. Sentinel lymph node mapping is an increasingly important treatment option in the management of breast cancer. We have demonstrated their potential for lymph node mapping by ex vivo imaging of regional lymph nodes after subcutaneous injection in the paw of rats. Using photoluminescence imaging and chemical extraction measurements based on elemental analysis by inductively coupled plasma mass spectroscopy, the quantum dots are shown to accumulate quickly and selectively in the axillary and thoracic regional lymph nodes. In addition, lifetime imaging microscopy of the QD photoluminescence indicates minimal perturbation to their photoluminescence properties in biological systems.

Indexed as

AnimalsFemaleIndiumLuminescent MeasurementsMetal NanoparticlesMetals, HeavyQuantum DotsRatsReproducibility of ResultsSensitivity and SpecificitySentinel Lymph NodeTissue DistributionIndiumMetals, HeavyBreast cancerHeavy metal-free quantum dotsNanoparticlesNanotechnologyPhotoluminescenceSentinel lymph node

Identifiers

PMID27454064
PMCPMC4993815
OpenAlexW2462737466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.